Wcm Investment Management, LLC Reata Pharmaceuticals Inc Transaction History

Wcm Investment Management, LLC

  • $38.6 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022
SELL
$25.61 - $110.96 $691,393 - $3 Million
-26,997 Closed
0 $0
Q3 2021

Nov 02, 2021
BUY
$100.0 - $143.02 $42,100 - $60,211
421 Added 1.58%
26,997 $2.72 Million
Q2 2021

Aug 05, 2021
SELL
$78.27 - $151.29 $1.13 Million - $2.18 Million
-14,383 Reduced 35.12%
26,576 $3.76 Million
Q1 2021

May 13, 2021
BUY
$94.25 - $132.81 $1.38 Million - $1.95 Million
14,647 Added 55.67%
40,959 $4.08 Million
Q4 2020

Feb 16, 2021
BUY
$102.03 - $184.62 $11,835 - $21,415
116 Added 0.44%
26,312 $3.25 Million
Q3 2020

Nov 06, 2020
BUY
$93.53 - $163.34 $144,129 - $251,706
1,541 Added 6.25%
26,196 $2.55 Million
Q2 2020

Aug 18, 2020
BUY
$126.3 - $176.56 $1.61 Million - $2.26 Million
12,773 Added 107.5%
24,655 $3.85 Million
Q1 2020

May 08, 2020
BUY
$124.16 - $247.74 $429,966 - $857,923
3,463 Added 41.13%
11,882 $1.72 Million
Q4 2019

Feb 07, 2020
BUY
$74.57 - $217.92 $157,342 - $459,811
2,110 Added 33.44%
8,419 $1.72 Million
Q3 2019

Oct 25, 2019
SELL
$71.26 - $95.75 $158,197 - $212,565
-2,220 Reduced 26.03%
6,309 $507,000
Q2 2019

Aug 06, 2019
SELL
$77.72 - $94.35 $21,217 - $25,757
-273 Reduced 3.1%
8,529 $804,000
Q1 2019

May 13, 2019
BUY
$51.9 - $101.79 $456,823 - $895,955
8,802 New
8,802 $752,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Wcm Investment Management, LLC Portfolio

Follow Wcm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wcm Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email